Sales@medsciencepharm.com    +86-396-2967988
Cont

Have any Questions?

+86-396-2967988

Nov 12, 2025

How does Carbetocin (CAS 37025 - 55 - 1) work on the smooth muscle of the uterus?

Carbetocin, identified by the CAS number 37025 - 55 - 1, is a synthetic analogue of oxytocin with significant implications for the smooth muscle of the uterus. As a trusted supplier of Carbetocin CAS 37025-55-1, I am excited to delve into the intricate mechanisms through which this compound exerts its effects on uterine smooth muscle.

The Basics of Uterine Smooth Muscle

Uterine smooth muscle, also known as myometrium, plays a crucial role in the female reproductive system. During pregnancy, the myometrium undergoes significant changes to accommodate the growing fetus. At the time of parturition, it contracts rhythmically to expel the fetus and placenta. These contractions are tightly regulated by a complex interplay of hormonal and neural signals.

The myometrial cells are unique in their ability to contract and relax. They contain actin and myosin filaments, which interact to generate force and cause muscle contraction. The regulation of these contractions is essential for a successful pregnancy and a safe delivery.

Carbetocin: An Overview

Carbetocin is a long - acting synthetic peptide that mimics the action of oxytocin. Oxytocin is a naturally occurring hormone produced by the hypothalamus and released by the posterior pituitary gland. It is well - known for its role in stimulating uterine contractions during labor and promoting milk ejection during breastfeeding.

Carbetocin has several advantages over natural oxytocin. It has a longer half - life, which means it remains active in the body for a more extended period. This property makes it a valuable tool in the management of postpartum hemorrhage, which is a leading cause of maternal mortality worldwide.

Mechanism of Action on Uterine Smooth Muscle

Receptor Binding

The first step in the action of carbetocin on uterine smooth muscle is its binding to oxytocin receptors. These receptors are G - protein - coupled receptors located on the surface of myometrial cells. When carbetocin binds to the oxytocin receptor, it activates a series of intracellular signaling pathways.

The binding of carbetocin to the receptor causes a conformational change in the receptor, which then activates a G - protein. There are different types of G - proteins, but in the case of uterine smooth muscle, the G - protein involved is typically Gq. Activation of Gq leads to the activation of phospholipase C (PLC).

Intracellular Signaling Pathways

Once activated, PLC cleaves phosphatidylinositol 4,5 - bisphosphate (PIP2) into two second messengers: inositol 1,4,5 - trisphosphate (IP3) and diacylglycerol (DAG).

IP3 diffuses into the cytoplasm and binds to IP3 receptors on the endoplasmic reticulum. This binding causes the release of calcium ions (Ca²⁺) from the endoplasmic reticulum into the cytoplasm. The increase in cytoplasmic Ca²⁺ concentration is a critical event in muscle contraction.

DAG, on the other hand, remains in the cell membrane and activates protein kinase C (PKC). PKC phosphorylates various proteins involved in the regulation of muscle contraction, further enhancing the contractile response.

Calcium - Dependent Contraction

The increased cytoplasmic Ca²⁺ binds to calmodulin, a calcium - binding protein. The Ca²⁺ - calmodulin complex then activates myosin light - chain kinase (MLCK). MLCK phosphorylates the regulatory light chain of myosin, which allows myosin to interact with actin. This interaction between myosin and actin leads to the formation of cross - bridges and the generation of force, resulting in muscle contraction.

In addition to the IP3 - mediated calcium release, carbetocin may also enhance the influx of extracellular calcium through voltage - gated calcium channels. This additional calcium source further contributes to the increase in cytoplasmic calcium concentration and the strength of muscle contraction.

Clinical Significance

The ability of carbetocin to stimulate uterine smooth muscle contractions has significant clinical applications. In the context of obstetrics, it is primarily used for the prevention of postpartum hemorrhage. Postpartum hemorrhage occurs when the uterus fails to contract adequately after delivery, leading to excessive bleeding.

By administering carbetocin, healthcare providers can ensure that the uterine smooth muscle contracts effectively, reducing the risk of hemorrhage. Its long - acting nature means that a single dose can provide sustained uterine contractions, which is particularly beneficial in resource - limited settings where continuous monitoring and repeated dosing may not be feasible.

Comparison with Other Related Compounds

In the field of reproductive medicine, there are other compounds that also target uterine smooth muscle. For example, HCG Chorionic Gonadotrophin CAS 9002 - 61 - 3 is a hormone that is mainly used in the treatment of infertility. It acts on the ovaries to stimulate the production of estrogen and progesterone, which in turn can have indirect effects on the uterine environment.

Another compound is Alarelin Acetate For Animals. It is a gonadotropin - releasing hormone (GnRH) analogue used in veterinary medicine to regulate the reproductive cycle. While these compounds have their own unique mechanisms of action, they do not directly target the uterine smooth muscle in the same way as carbetocin.

Our Role as a Supplier

As a supplier of Carbetocin CAS 37025 - 55 - 1, we are committed to providing high - quality products to our customers. Our carbetocin is manufactured under strict quality control standards to ensure its purity, potency, and safety.

We understand the importance of this compound in the medical field, especially in the prevention of postpartum hemorrhage. Our team of experts is dedicated to researching and developing new formulations and delivery methods to enhance the efficacy of carbetocin.

Conclusion

Carbetocin is a remarkable compound that has revolutionized the management of postpartum hemorrhage. Its ability to target the uterine smooth muscle through a well - defined mechanism of action makes it a valuable tool in obstetrics. By binding to oxytocin receptors and activating intracellular signaling pathways, carbetocin stimulates strong and sustained contractions of the myometrium.

If you are interested in purchasing Carbetocin CAS 37025 - 55 - 1 for your research or clinical needs, we invite you to contact us for further discussion. Our team is ready to provide you with detailed information and support to ensure a successful procurement process.

HCGAlarelin Acetate For Animals

References

  1. Magon N, Gupta S. Oxytocin and its analogues in labour. Indian J Anaesth. 2014;58(3):273 - 280.
  2. World Health Organization. Prevention of postpartum haemorrhage. Geneva: World Health Organization; 2012.
  3. Fuchs AR, Fuchs F. Oxytocin and the initiation of human labor. Am J Obstet Gynecol. 1984;149(6):787 - 795.

Send Inquiry